31 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... Penicilliosis #Prophylaxis ... #Opportunistic ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... Penicilliosis #Prophylaxis ... #Opportunistic ... IDSA #management #pharmacology
HIV Associated Infections Based on CD4 Count 

#Diagnosis #InfectiousDisease #CD4Count #HIV #AIDS #Opportunistic #Infections #OI #Table
HIV Associated Infections ... InfectiousDisease #CD4Count #HIV ... #AIDS #Opportunistic ... Infections #OI #Table ... #Prophylaxis #CD4
Loop diuretic conversion - Equivalent Doses
Furosemide (Lasix) 40 mg PO = Furosemide 20 mg IV =
Doses Furosemide (Lasix ... #Pharmacology ... #Cardiology #Loop ... Doses #Conversion #Table ... Torsemide #Bumex #Lasix
Loop diuretic PO --> IV conversions 

Furosemide 40 mg PO = Furosemide 20 mg IV =
#Pharmacology ... #Cardiology #Loop ... Dose #Conversion #Table ... Torsemide #Bumex #Lasix ... Text: Clinical Pharmacology
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - Pharmacology ... Comparison Table ... line) Esmolol (IV ... Variceal bleed prophylaxis ... #Receptors #cardiology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... amphotericin B, 3 to 5 mg/kg ... /day IV for 2 weeks ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Antimicrobial prophylaxis ... antimicrobial prophylaxis ... (TMP-SMX) for prophylaxis ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... IV daily or • ... IV daily for 10 ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... mucoadhesive buccal tablet ... chew, or crush tablet ... Treatment #management #opportunistic ... infections #HIVAIDS #pharmacology